CEL-SCI Corporation Receives Russian Government Approval to Commence Phase III Clinical Trial

CEL-SCI Corporation CVM announced today it has received governmental approval from the Ministry of Health Care and Social Development of the Russian Federation to begin enrollment of subjects for a Phase III clinical trial of Multikine in Russia.